Germany
Japan
United Kingdom
China
Research Areas
View as table Download
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5E4
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 428.00
In Stock
USD 515.00
In Stock
Estrogen Receptor 1 (ESR1) rabbit monoclonal antibody, clone SP1, Supernatant
| Applications | IHC, WB |
| Reactivities | Hamster, Human, Mouse, Rat |
CD3E (Cytopl. Dom.) rabbit monoclonal antibody, clone SP7, Supernatant
| Applications | IHC, WB |
| Reactivities | Canine, Equine, Feline, Human |
c Kit (KIT) (C-term) rabbit monoclonal antibody, clone YR145, Supernatant
| Applications | IHC |
| Reactivities | Human |
CD5 rabbit monoclonal antibody, clone SP19, Supernatant
| Applications | IHC |
| Reactivities | Human |
CD8A rabbit monoclonal antibody, clone SP16, Supernatant
| Applications | IHC |
| Reactivities | Human |
CD23 rabbit monoclonal antibody, clone SP23, Supernatant
| Applications | IHC |
| Reactivities | Human |
Rabbit Monoclonal CD14 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit Monoclonal CD1a Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit Monoclonal CD21 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit Monoclonal CD3 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit Monoclonal NCAM1 (CD56) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit Monoclonal CD99 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Phospho-Dishevelled 2 (Ser143) Rabbit monoclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
USD 380.00
4 Weeks
MHC Class I Rabbit monoclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Integrin beta 3 Rabbit monoclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Galectin 3 Rabbit monoclonal Antibody
| Applications | IF, WB |
| Reactivities | Human, Monkey, Rat |
| Conjugation | Unconjugated |
JNK Rabbit monoclonal Antibody
| Applications | IP, WB |
| Reactivities | Hamster, Human, Mouse, Rat |
| Conjugation | Unconjugated |
JNK Rabbit monoclonal Antibody
| Applications | IF, IP, WB |
| Reactivities | Mouse, Rat |
| Conjugation | Unconjugated |
JNK2 Rabbit monoclonal Antibody
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CD3 epsilon (Clone UCHT1)
| Applications | FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD3 epsilon (Clone OKT-3 (muromonab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD34 (Clone My10)
| Applications | FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-18 (Clone 125-2H)
| Applications | ELISA, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD2 (Clone YTH 655)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone YNB46.1.8 (Campath-9H))
| Applications | FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Active filters
Category
-
Antibodies
- Primary Antibodies
Antibody Hosts
- Rabbit
Clonalities
- Monoclonal
Filter by
Target Symbol
- CD274 (6)
- CD4 (6)
- IL2RA (5)
- CD19 (4)
- CD3E (4)
- CD8A (4)
- IL3RA (4)
- CD74 (3)
- ESR1 (3)
- IL18 (3)
- ITGA2B (3)
- TNF (3)
- CD1A (2)
- CD33 (2)
- LGALS3 (2)
- MAPK8 (2)
- MME (2)
- NCAM1 (2)
- PECAM1 (2)
- TNFRSF8 (2)
- WNT3A (2)
- ANPEP (1)
- CALR (1)
- CD14 (1)
- CD2 (1)
- CD22 (1)
- CD34 (1)
- CD3D (1)
- CD3G (1)
- CD5 (1)
- CD7 (1)
- CD99 (1)
- CR2 (1)
- DVL2 (1)
- FCER2 (1)
- FCGR1A (1)
- HLA CLASS II (1)
- HLA-A (1)
- IL10 (1)
- IL1RN (1)
- IL2 (1)
- IL6R (1)
- IL6RA (1)
- ITGAX (1)
- ITGB3 (1)
- MAPK9 (1)
- MS4A1 (1)
- PTPRC (1)
- ROR2 (1)
- TCF7L2 (1)
- TLR2 (1)
- WNT5B (1)
Reactivities
Applications
Isotypes
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (11)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (21)
- Transmembrane (16)
- ES Cell Differentiation/IPS (8)
- Adult stem cells (5)
- Secreted Protein (5)
- Cancer stem cells (2)
- Induced pluripotent stem cells (2)
- Nuclear Hormone Receptor (2)
- Stem cell relevant signaling - Wnt Signaling pathway (2)
- Transcription Factors (2)
- Embryonic stem cells (1)
- Protease (1)
- Protein Kinase (1)
Pathways
- Cell adhesion molecules (CAMs) (9)
- Hematopoietic cell lineage (9)
- Basal cell carcinoma (3)
- Hedgehog signaling pathway (3)
- Melanogenesis (3)
- Pathways in cancer (3)
- Primary immunodeficiency (3)
- T cell receptor signaling pathway (3)
- Wnt signaling pathway (3)
- Antigen processing and presentation (2)
- B cell receptor signaling pathway (1)
- Complement and coagulation cascades (1)
- Cytokine-cytokine receptor interaction (1)
- Endocytosis (1)
- Glutathione metabolism (1)
- Jak-STAT signaling pathway (1)
- Leukocyte transendothelial migration (1)
- MAPK signaling pathway (1)
- Metabolic pathways (1)
- Pathogenic Escherichia coli infection (1)
- Prion diseases (1)
- Regulation of actin cytoskeleton (1)
- Renin-angiotensin system (1)
- Toll-like receptor signaling pathway (1)